menu
    • menu

    Company profile for AEON Biopharma

    NEW Drugs in Dev: 3
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AEON Biopharma is a bio-pharmaceutical company focused on developing a proprietary 900 kDabotulinum toxin complex, ABP-450, for debilitating medical conditions. We are committed to developing novel and proprietary treatment paradigms to improve patient outcomes and drive enhanced value to patients, physicians, and payers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AEON BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4040 MACARTHUR BL. SUITE 260 NEWPORT BEACH, California 92660, US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aeonbiopharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AEON Biopharma Reports 2025 Results and Positive ABP-450 Data
    AEON Biopharma Reports 2025 Results and Positive ABP-450 Data

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3265006/0/en/AEON-Biopharma-Reports-Full-Year-2025-Financial-Results-and-Highlights-Positive-Comparative-Analytical-Results-and-FDA-Feedback-for-ABP-450-Biosimilar-Program.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    AEON Bio Receives FDA Feedback On ABP-450 Biosimilar Program
    AEON Bio Receives FDA Feedback On ABP-450 Biosimilar Program

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262144/0/en/AEON-Biopharma-Announces-FDA-Feedback-Following-BPD-Type-2a-Meeting-for-the-ABP-450-Biosimilar-Program.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    AEON Biopharma Appoints John Bencich as Chief Financial Officer
    AEON Biopharma Appoints John Bencich as Chief Financial Officer

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3252300/0/en/AEON-Biopharma-Appoints-John-Bencich-as-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    AEON Biopharma Abstract Accepted for AAN 2026 Presentation
    AEON Biopharma Abstract Accepted for AAN 2026 Presentation

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250670/0/en/AEON-Biopharma-Abstract-Accepted-for-Presentation-at-2026-American-Academy-of-Neurology-AAN-Annual-Meeting.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    AEON Biopharma Holds FDA Meeting on BPD Type 2A
    AEON Biopharma Holds FDA Meeting on BPD Type 2A

    21 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/21/3223230/0/en/AEON-Biopharma-Reports-BPD-Type-2a-Meeting-with-FDA-and-Shareholder-Approval-of-the-November-Transactions.html

    GLOBENEWSWIRE
    21 Jan 2026
    Share Share
    AEON Bio Reports Inducement Grants Per NYSE American LLC Guide
    AEON Bio Reports Inducement Grants Per NYSE American LLC Guide

    19 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/19/3208775/0/en/AEON-Biopharma-Reports-Inducement-Grants-Under-NYSE-American-LLC-Company-Guide-Section-711.html

    GLOBENEWSWIRE
    19 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search